BLEECKER (BLEE.PA) Stock Fundamental Analysis
Europe - EPA:BLEE - FR0000062150 - Common Stock
109 EUR
0 (0%)
Overall BLEE gets a fundamental rating of 2 out of 10. We evaluated BLEE against 41 industry peers in the Diversified REITs industry. BLEE may be in some trouble as it scores bad on both profitability and health. BLEE has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLEE has reported negative net income.
BLEE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLEE reported negative net income in multiple years.
BLEE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BLEE has a worse Return On Assets (-4.02%) than 85.37% of its industry peers.
BLEE's Return On Equity of -9.23% is on the low side compared to the rest of the industry. BLEE is outperformed by 85.37% of its industry peers.
The Return On Invested Capital of BLEE (1.44%) is worse than 80.49% of its industry peers.
BLEE had an Average Return On Invested Capital over the past 3 years of 0.99%. This is below the industry average of 3.46%.
The last Return On Invested Capital (1.44%) for BLEE is above the 3 year average (0.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.02% | ||
| ROE | -9.23% | ||
| ROIC | 1.44% |
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
1.3 Margins
BLEE has a Operating Margin of 41.14%. This is in the lower half of the industry: BLEE underperforms 75.61% of its industry peers.
BLEE's Operating Margin has improved in the last couple of years.
BLEE's Gross Margin of 48.62% is on the low side compared to the rest of the industry. BLEE is outperformed by 75.61% of its industry peers.
BLEE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 41.14% | ||
| PM (TTM) | N/A | ||
| GM | 48.62% |
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLEE is destroying value.
BLEE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BLEE has about the same amount of shares outstanding.
The debt/assets ratio for BLEE has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.89, we must say that BLEE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.89, BLEE perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
BLEE has a debt to FCF ratio of 134.87. This is a negative value and a sign of low solvency as BLEE would need 134.87 years to pay back of all of its debts.
BLEE has a worse Debt to FCF ratio (134.87) than 80.49% of its industry peers.
BLEE has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
BLEE has a Debt to Equity ratio of 1.17. This is amonst the worse of the industry: BLEE underperforms 82.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.17 | ||
| Debt/FCF | 134.87 | ||
| Altman-Z | 0.89 |
ROIC/WACC0.34
WACC4.25%
2.3 Liquidity
A Current Ratio of 0.93 indicates that BLEE may have some problems paying its short term obligations.
BLEE has a Current ratio of 0.93. This is in the better half of the industry: BLEE outperforms 75.61% of its industry peers.
BLEE has a Quick Ratio of 0.93. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
BLEE has a Quick ratio of 0.93. This is amongst the best in the industry. BLEE outperforms 80.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 37.64% over the past year.
The Revenue has decreased by -9.71% in the past year.
BLEE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.33% yearly.
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
Revenue 1Y (TTM)-9.71%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%-20.78%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BLEE. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
BLEE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. BLEE is more expensive than 78.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.79 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BLEE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:BLEE (11/18/2025, 7:00:00 PM)
109
0 (0%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap123.17M
Revenue(TTM)26.78M
Net Income(TTM)-23.69M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.6 | ||
| P/FCF | 53.79 | ||
| P/OCF | 13.24 | ||
| P/B | 0.48 | ||
| P/tB | 0.49 | ||
| EV/EBITDA | N/A |
EPS(TTM)-21.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.03
FCFY1.86%
OCF(TTM)8.24
OCFY7.56%
SpS23.7
BVpS227.11
TBVpS224.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.02% | ||
| ROE | -9.23% | ||
| ROCE | 1.96% | ||
| ROIC | 1.44% | ||
| ROICexc | 1.44% | ||
| ROICexgc | 1.45% | ||
| OM | 41.14% | ||
| PM (TTM) | N/A | ||
| GM | 48.62% | ||
| FCFM | 8.55% |
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
ROICexc(3y)0.99%
ROICexc(5y)0.84%
ROICexgc(3y)1%
ROICexgc(5y)0.84%
ROCE(3y)1.34%
ROCE(5y)1.13%
ROICexgc growth 3Y47.05%
ROICexgc growth 5Y20.23%
ROICexc growth 3Y47.05%
ROICexc growth 5Y20.22%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
F-Score5
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.17 | ||
| Debt/FCF | 134.87 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 26.2% | ||
| Interest Coverage | 0.6 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 0.89 |
F-Score5
WACC4.25%
ROIC/WACC0.34
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.61%
Cap/Sales(5y)36.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.71%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%-20.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.65%
EBIT growth 3Y45.94%
EBIT growth 5Y17.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1661.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y189.01%
OCF growth 3Y120.64%
OCF growth 5Y3.91%
BLEECKER / BLEE.PA FAQ
Can you provide the ChartMill fundamental rating for BLEECKER?
ChartMill assigns a fundamental rating of 2 / 10 to BLEE.PA.
What is the valuation status of BLEECKER (BLEE.PA) stock?
ChartMill assigns a valuation rating of 0 / 10 to BLEECKER (BLEE.PA). This can be considered as Overvalued.
Can you provide the profitability details for BLEECKER?
BLEECKER (BLEE.PA) has a profitability rating of 3 / 10.
Can you provide the financial health for BLEE stock?
The financial health rating of BLEECKER (BLEE.PA) is 2 / 10.